Idiopathic intracranial hypertension after 40 years of age: Clinical features in 23 patients

European Journal of Ophthalmology

Volumn 18, Issue 6, 2008, Pages 989-993

  Zayit Soudry, S ^a   Leibovitch, I ^a   Kesler, Anat ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Idiopathic intracranial hypertension; Late onset; Pseudotumor cerebri; Visual symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SYMPTOMATOLOGY; VISUAL DISORDER; AGE DISTRIBUTION; BRAIN PSEUDOTUMOR; INTRACRANIAL PRESSURE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; FEMALE; HEADACHE; HUMANS; HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; PSEUDOTUMOR CEREBRI; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; VISION DISORDERS;

EID: 58149393432     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800621     Document Type: Article

References (31)

1. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro-ophthalmol 2004; 24: 138-45.
2. Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1937; 106: 492-513.
3. Smith JL. Whence pseudotumor cerebri? J Clin Neuro-phthalmol 1985; 5: 55-6.
4. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-5.
5. Durcan J, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-7.
6. Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45: 866-72.
7. Kesler A, Goldhammer Y, Gadoth N. Do men with pseudotumor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuro-ophthalmol 2001; 21: 15-7.
8. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37: 155-66.
9. Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52: 870-2.
10. Dhiravibulya K, Ouvrier R, Johnston I, et al. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health 1991; 27: 304-7.
11. Bandyopadhyay S, Jacobson DM. Clinical features of late- onset pseudotumor cerebri fulfilling the modified dandy criteria. J Neuro-ophthalmol 2002; 22: 9-11.
12. Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992; 59: 419-22.
13. Guy J, Johnston PK, Corbett JJ, et al. Treatment of visual loss in pseudotumor cerebri associated with uremia. Neurology 1990; 40: 28-32.
14. Huseman CA, Torkelson RD. Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 1984; 138: 927-31.
15. Campos SP, Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr 1995; 34: 334-7.
16. Morrice G, Havener WH, Kapetanxky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 1960; 173: 1802-5.
17. Binder DK, Horton JC, Lawton MT, et al. Idiopathic intracranial hypertension. Neurosurgery 2004; 54: 538-52.
18. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126: 116-21.
19. Giles C, Soble A. Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 1971; 72: 981-2.
20. Walsh FB, Clark DB, Thompson RS. Oral contraceptives and neuro-ophthalmologic interest. Arch Ophthalmol 1965; 74: 628-40.
21. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114: 155-80.
22. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41: 239-44.
23. Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol 2006; 5: 433-42.
24. Galvin J, Van Stavern G. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004; 223: 157-60.
25. Kesler A, Hadayer A, Goldhammer Y, et al. Idiopathic intracranial hypertension. Risk of recurrences. Neurology 2004; 63: 1737-9.
26. Ireland B, Corbett J, Wallace R. The search for causes of idiopathic intracranial hypertension: a preliminary case control study. Arch Neurol 1990: 47: 315-20.
27. Brown MJ. Hypertension and ethnic group. BMJ 2006; 332: 833-6.
28. Pleis JR, Coles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1998. Vital Health Stat 10 2002; 209: 1-113.
29. Orcutt JC, Page NGR, Sandres MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984; 91: 1303-12.
30. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri follow up of 57 patients from 5-41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39: 461-74.
31. Rish BL, Meacham WF. Pseudotumor cerebri: a historical and clinical review. J Tenn Med Assoc 1965; 58: 355-61.